Senseonics Holdings Inc (SENS) Short Interest Update
Senseonics Holdings Inc (NYSEAMERICAN:SENS) was the target of a large decrease in short interest during the month of December. As of December 29th, there was short interest totalling 3,864,087 shares, a decrease of 5.5% from the December 15th total of 4,088,887 shares. Based on an average daily trading volume, of 307,944 shares, the short-interest ratio is currently 12.5 days. Approximately 8.0% of the company’s shares are sold short.
Shares of Senseonics (NYSEAMERICAN:SENS) opened at $3.10 on Friday. Senseonics has a twelve month low of $1.26 and a twelve month high of $3.67. The stock has a market capitalization of $423.94 and a price-to-earnings ratio of -6.20. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.93 and a quick ratio of 2.81.
Senseonics (NYSEAMERICAN:SENS) last announced its quarterly earnings results on Tuesday, October 31st. The company reported ($0.13) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.13). Senseonics had a negative return on equity of 406.72% and a negative net margin of 828.76%. The firm had revenue of $2.10 million during the quarter, compared to the consensus estimate of $1.51 million. Senseonics’s quarterly revenue was up 425.0% on a year-over-year basis. equities analysts anticipate that Senseonics will post -0.54 earnings per share for the current year.
In other news, major shareholder Peter J. Barris sold 139,645 shares of the company’s stock in a transaction on Friday, December 8th. The stock was sold at an average price of $2.63, for a total transaction of $367,266.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 34.10% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Raymond James Financial Services Advisors Inc. boosted its position in Senseonics by 221.4% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 263,562 shares of the company’s stock valued at $474,000 after buying an additional 181,562 shares during the last quarter. Goldman Sachs Group Inc. purchased a new position in Senseonics in the 2nd quarter valued at about $276,000. Susquehanna International Group LLP purchased a new position in Senseonics in the 2nd quarter valued at about $155,000. Citadel Advisors LLC purchased a new position in Senseonics in the 3rd quarter valued at about $194,000. Finally, Perceptive Advisors LLC purchased a new position in Senseonics in the 3rd quarter valued at about $160,000. Hedge funds and other institutional investors own 30.66% of the company’s stock.
Separately, Canaccord Genuity reiterated a “buy” rating on shares of Senseonics in a report on Thursday, September 28th.
Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with Analyst Ratings Network's FREE daily email newsletter.